Breast Cancer medicine pain reduced with 4300 IU vitamin D – RCT

Highlight from Vitamin D May Help Breast Cancer Survivors Stay on Track Medscape Medical News

2012 Annual Meeting of the American Society of Clinical Oncology®

• aromatase inhibitors
  • half of the women have severe musculoskeletal pain from these agents, and 18% to 30% report fatigue, [resulting in] a discontinuation rate of about 10% each year,"

• 30,000 IU of oral vitamin D3 weekly on starting letrozole therapy achieved significant benefits in terms of fatigue, joint pain, and disability from joint pain.

• Using the Simple Descriptive Pain Intensity

  • 37% of women receiving vitamin D3
  • 51% of those in the placebo group
• adverse quality of life events = 42% vs 72%

Note: aromatase inhibitors reduction of bone causes pain

See also VitaminDWiki

• Overview Chronic Pain and Vitamin D

• All items in category Breast Cancer and Vitamin D

• Aromatase inhibitor chemotherapy after breast cancer not associated with vitamin D levels – Dec 2011

• Breast cancer survivors and vitamin D: A review PDF file

• Google search of Vitamin DWiki for Aromatase 111 items as of May 2015

• Vitamin D after breast cancer diagnosis

• All items in category Breast Cancer and Vitamin D items

• Overview Breast Cancer and Vitamin D

• Breast Cancer aromatase therapy can cause sore tendons if low vitamin D – March 2015